Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.1900 (0.13%) ($15.1900 - $15.1900) on Tue. Oct. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.05% (three month average) | RSI | 36 | Latest Price | $15.1900(0.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -5.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) IBB(47%) ARKG(46%) ARKK(46%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.525% in a week (0% probabilities). VIXM(-40%) VXX(-29%) UNG(-15%) USO(-11%) TLT(-11%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.525% (StdDev 3.05%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $16.39 | 5 Day Moving Average | $15.56(-2.38%) | 10 Day Moving Average | $15.42(-1.49%) | 20 Day Moving Average | $16.39(-7.32%) | To recent high | -15.3% | To recent low | 26.5% | Market Cap | $1.129b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |